3 ms·
This makes no sense. Their competition from week 2 at least, Moderna and Oxford, were already capable of transport and storage at regular freezer temps. Johnso
by addicted 6y ago
This makes no sense. Their competition from week 2 at least, Moderna and Oxford, were already capable of transport and storage at regular freezer temps.
Johnson and Johnson doesn’t add easier temps to the mix. It adds the fact that it’s a single dose vaccine to the environment.
If you did think it was competitive pressure that was driving it then you should be suspicious about the Israeli studies that show that a single dose of thrnPfizer vaccine is 85% effective upto 4 months later.
- hef19898 6y agoDepends where you are. In Europe, we have Biontech and AZ. Thanks to aggressive PR and media campaigns, nobody wants AZ in Germany. Even the surplus AZ doses are just sitting in storage, official centers don't use them if you are not eligible yet. Even if that means less people are getting shots. As soon as doctors are jumping in, that will change. We also have, quite likely, an incredible amount or surplus doses come Q2, early Q3.